[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519037":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":31,"responsibleParty":91,"collaborators":19,"id":93,"slug":19,"hasResults":94,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":19,"eligibilityCriteria":98,"healthyVolunteers":94,"sex":99,"minAge":100,"maxAge":101,"enrollmentInfo":102,"targetDuration":19,"studyType":105,"phases":106,"briefSummary":108,"conditions":109,"keywords":111,"overallStatus":34,"whyStopped":19,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":122},{"fullName":5,"class":6},"TBF Genie Tissulaire","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"SclerFIX-IP","EXPERIMENTAL","Treated, devitalised and sterile graft of umbilical cord amniotic membrane",[13],"Biological: SclerFIX-IP",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"BIOLOGICAL","Decellularized, viro-inactivated, freeze-dried and sterile allogeneic graft of amniotic membrane of umbilical cord used as an interposition implant in the STT joint",[9],null,[21,27],{"name":22,"role":23,"phone":24,"phoneExt":25,"email":26},"Laurence BARNOUIN, MD","CONTACT","4 72 68 69 09","+33","laurence.barnouin@tbf-lab.com",{"name":28,"role":23,"phone":29,"phoneExt":25,"email":30},"Justine BOSC, MSc","4 72 68 69 11","justine.bosc@tbf-lab.com",[32,49,63,76],{"facility":33,"status":34,"city":35,"state":19,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"CHU de Besançon","RECRUITING","Besançon","25030","France",{"type":39,"coordinates":40},"Point",[41,42],6.01815,47.24878,{"lat":42,"lon":41},[45,47],{"name":46,"role":23,"phone":19,"phoneExt":19,"email":19},"François LOISEL, MD",{"name":46,"role":48,"phone":19,"phoneExt":19,"email":19},"PRINCIPAL_INVESTIGATOR",{"facility":50,"status":34,"city":51,"state":19,"zip":52,"country":37,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Institut Chirurgical de la Main et du Membre Supérieur (ICMMS)","Lyon","69006",{"type":39,"coordinates":54},[55,56],4.84789,45.74906,{"lat":56,"lon":55},[59,62],{"name":60,"role":23,"phone":19,"phoneExt":19,"email":61},"Lionel ERHARD, MD","lionel.erhard@institut-chirurgical.com",{"name":60,"role":48,"phone":19,"phoneExt":19,"email":19},{"facility":64,"status":34,"city":65,"state":19,"zip":66,"country":37,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"Centre de la Main - Clinique Jules Verne","Nantes","44300",{"type":39,"coordinates":68},[69,70],-1.55336,47.21725,{"lat":70,"lon":69},[73,75],{"name":74,"role":23,"phone":19,"phoneExt":19,"email":19},"Edward de KEATING-HART, MD",{"name":74,"role":48,"phone":19,"phoneExt":19,"email":19},{"facility":77,"status":34,"city":78,"state":19,"zip":79,"country":37,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Hôpitaux Universitaires de Strasbourg","Strasbourg","67200",{"type":39,"coordinates":81},[82,83],7.74553,48.58392,{"lat":83,"lon":82},[86,88],{"name":87,"role":48,"phone":19,"phoneExt":19,"email":19},"Sybille FACCA, Professor",{"name":89,"role":90,"phone":19,"phoneExt":19,"email":19},"Kursat ERDOGAN, MD","SUB_INVESTIGATOR",{"type":92,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100519037",false,"NCT06038331","Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis","Evaluation of the Treatment of Symptomatic Scaphotrapeziotrapezoidal (STT) Osteoarthritis With a Treated, Devitalized and Sterile Amniotic Membrane of Umbilical Cord Placed in Joint Interposition","Inclusion Criteria:\n\n* Male or female; age between 18 and 75 years.\n* Patient with symptomatic STT OA.\n* Patient treated medically for functional signs for more than 3 months, without improvement, justifying a surgical intervention.\n* Patient with a QuickDash score \\> 33 points (converted to 50%).\n* Patient with wrist pain in front of the STT joint at rest = or \\> 4\u002F10 on VAS.\n* Patient who received the study information and provided consent.\n* Member or beneficiary of a national health insurance plan.\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding woman; woman without effective contraception.\n* Patient with functional rhizarthrosis that has not been stabilized or treated medically or surgically.\n* Patient with signs of neuropathy with functional disorders such as hyperesthesia.\n* Patient with uncontrolled epilepsy or neuropathy that contraindicates locoregional anesthesia.\n* Person confined by a judicial or administrative decision.\n* Adult subjected to legal protection measures or unable to provide his\u002Fher consent.","ALL","18 Years","75 Years",{"count":103,"type":104},14,"ESTIMATED","INTERVENTIONAL",[107],"PHASE2","The aim of this open, prospective, multicenter trial is to evaluate the use of a sterile, devitalized, processed umbilical cord amniotic membrane implant placed in joint interposition in the treatment of STT osteoarthritis.",[110],"Osteoarthritis Hand",[112],"ScaphoTrapezioTrapezoid OsteoArthritis (STT OA)","2025-09-24",{"date":115,"type":116},"2025-09-30","ACTUAL",{"date":118,"type":116},"2024-05-28",{"date":120,"type":104},"2026-12",{"name":5,"class":6},4]